Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.93 Insider Own44.22% Shs Outstand28.80M Perf Week-0.20%
Market Cap4.30M Forward P/E- EPS next Y-0.39 Insider Trans3.24% Shs Float16.07M Perf Month-15.22%
Income-12.40M PEG- EPS next Q-0.09 Inst Own5.20% Short Float0.78% Perf Quarter-35.09%
Sales0.57M P/S7.54 EPS this Y77.60% Inst Trans- Short Ratio0.12 Perf Half Y-89.63%
Book/sh0.15 P/B0.99 EPS next Y4.88% ROA-200.61% Short Interest0.13M Perf Year-
Cash/sh0.10 P/C1.43 EPS next 5Y- ROE-5059.78% 52W Range0.14 - 5.18 Perf YTD-83.77%
Dividend Est.- P/FCF- EPS past 5Y- ROI-258.24% 52W High-97.12% Beta-1.77
Dividend TTM- Quick Ratio2.80 Sales past 5Y149.87% Gross Margin23.68% 52W Low5.51% ATR (14)0.02
Dividend Ex-Date- Current Ratio2.80 EPS Y/Y TTM- Oper. Margin-1575.13% RSI (14)33.82 Volatility10.10% 12.40%
Employees10 Debt/Eq0.19 Sales Y/Y TTM- Profit Margin-2165.66% Recom1.00 Target Price2.00
Option/ShortNo / Yes LT Debt/Eq0.11 EPS Q/Q44.58% Payout- Rel Volume0.49 Prev Close0.15
Sales Surprise- EPS Surprise- Sales Q/Q-100.00% EarningsMay 09 AMC Avg Volume1.03M Price0.15
SMA20-16.79% SMA50-25.32% SMA200-84.21% Trades Volume505,675 Change2.82%
May-31-24 08:00AM
May-17-24 08:00AM
May-10-24 08:00AM
May-09-24 05:00PM
Apr-22-24 04:30PM
04:15PM Loading…
Apr-18-24 04:15PM
Mar-15-24 04:15PM
Feb-16-24 04:05PM
Feb-13-24 10:09PM
Jan-16-24 09:00AM
Jan-03-24 09:00AM
Nov-14-23 04:30PM
Oct-16-23 08:00AM
Aug-29-23 08:00AM
Aug-14-23 04:05PM
04:05PM Loading…
Jul-19-23 04:05PM
Jul-11-23 04:05PM
Jun-21-23 06:46PM
Jun-15-23 07:04PM
Azitra, Inc. is an early-stage clinical biopharmaceutical company, which engages in the development of therapeutic use in dermatology. The firm is involved in using engineered proteins and live bio therapeutic products that can be applied topically to treat diseases of the skin. It also offers a platform which is augmented by artificial intelligence and machine learning technology that analyzes, predicts, and helps screen library of strains for drug like molecules. The company was founded by Azim Munivar and Travis Whitfill on January 2, 2014 and is headquartered in Branford, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Staskey NormChief Financial OfficerMar 29 '24Buy0.2147,60010,03451,100Apr 01 09:51 PM
Salva Francisco D.President and CEOFeb 13 '24Buy0.30333,30099,990338,300Feb 15 08:38 PM
Whitfill TravisChief Operating OfficerFeb 13 '24Buy0.3015,0004,500334,500Feb 15 08:42 PM
Staskey NormChief Financial OfficerFeb 13 '24Buy0.303,3009903,500Feb 15 08:39 PM
Kreis Leslie W.10% OwnerJun 21 '23Buy5.00600,0003,000,0001,747,670Jun 23 09:38 PM
Fletcher Aaron G.L.10% OwnerJun 21 '23Buy5.00600,0003,000,0001,747,670Jun 23 09:37 PM